Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft-tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT05264974
What this trial is testing

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Who this might be right for
MelanomaSoft Tissue Sarcoma
University of Florida 18
Early research (Phase 1)Study completedNCT04811196
What this trial is testing

Different Dosing Schedules of Selinexor in Sarcoma Patients

Who this might be right for
Soft Tissue SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Leiomyosarcoma+1 more
University Health Network, Toronto 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07355855
What this trial is testing

A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
Fudan University 106
Not applicableStudy completedNCT06162962
What this trial is testing

Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient

Who this might be right for
OsteosarcomaPediatricLower Limb Injury+1 more
Changye Zou 345
Testing effectiveness (Phase 2)Study completedNCT02470091
What this trial is testing

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+3 more
Children's Oncology Group 56
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Early research (Phase 1)Study completedNCT00002262
What this trial is testing

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT01553539
What this trial is testing

Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Bone CancerChondrosarcomaClear Cell Sarcoma of the Kidney+9 more
Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04874311
What this trial is testing

Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
Institut Bergonié 80
Post-approval studies (Phase 4)Study completedNCT03514381
What this trial is testing

Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Institut Claudius Regaud 59
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableTemporarily Not AvailableNCT03842865
What this trial is testing

Expanded Access of Vigil in Solid Tumors

Who this might be right for
Solid TumorEwing SarcomaEwing's Tumor Metastatic+5 more
Gradalis, Inc.
Testing effectiveness (Phase 2)Study completedNCT00390234
What this trial is testing

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more
National Cancer Institute (NCI) 63
Early research (Phase 1)Study completedNCT03056599
What this trial is testing

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma Adult
Presage Biosciences 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686198
What this trial is testing

Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to Severe Photodamage and Crepiness on the Forearms

Who this might be right for
Photodamaged Skin
Goldman, Butterwick, Fitzpatrick and Groff 20
Not applicableLooking for participantsNCT06829654
What this trial is testing

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

Who this might be right for
SarcomasHaematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Not applicableLooking for participantsNCT04132895
What this trial is testing

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa

Who this might be right for
Osteosarcoma
University College, London 300
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Study completedNCT03840772
What this trial is testing

Eribulin in Advanced Solitary Fibrous Tumor

Who this might be right for
Solitary Fibrous Tumor
Italian Sarcoma Group 16
Next Page